Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lebbe

Showing results (51-60 of 53) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 53 results.
The British Journal of Dermatology|November 25, 2020
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomesK A Reynolds, D I Schlessinger, A F Yanes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanomaP Grover, S N Lo, I Li, et al.
Pageof 6

Showing results (51-60 of 53) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 53 results.
The British Journal of Dermatology|November 25, 2020
Development of a core outcome set for cutaneous squamous cell carcinoma trials: identification of core domains and outcomesK A Reynolds, D I Schlessinger, A F Yanes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2024
Improved nationwide survival of sarcoma patients with a network of reference centersJ Y Blay, N Penel, T Valentin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2025
Efficacy of adjuvant therapy in patients with stage IIIA cutaneous melanomaP Grover, S N Lo, I Li, et al.
Pageof 6